Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
酗酒的临床神经科学:神经科学与临床试验的结合
基本信息
- 批准号:10481839
- 负责人:
- 金额:$ 18.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlcohol consumptionAlcoholismAlcoholsAreaAwardClinicalClinical InvestigatorClinical PsychologyClinical ResearchClinical TrialsDataData AnalysesData SetDevelopmentEducational process of instructingFacultyFundingGenerationsGoalsGroup MeetingsHeterogeneityHumanIndividualLaboratoriesLaboratory ResearchLaboratory StudyLatinaLevetiracetamManuscriptsMentorsMentorshipMethodsModelingNational Institute on Alcohol Abuse and AlcoholismNeurosciencesParticipantPatientsPharmaceutical PreparationsPharmacology StudyPhenotypePostdoctoral FellowPreparationPublicationsReportingResearchResearch EthicsResearch MethodologyResearch PersonnelResourcesSamplingScienceScientistSelf AdministrationServicesSeveritiesTestingTimeTrainingTraining ProgramsUnderrepresented Studentsalcohol cravingalcohol cuealcohol reinforcementalcohol researchalcohol responsealcohol rewardbehavioral pharmacologybehavioral studycareercareer developmentclinical investigationcue reactivityexperiencegraduate studentlecturesneuroimagingnovelpatient orientedprogramsquetiapineresearch and developmentresponsescreeningskillsstudent mentoringsynergismtherapy developmenttreatment comparisonundergraduate studentvarenicline
项目摘要
PROJECT SUMMARY/ABSTRACT
This application for a Mid-Career Investigator Award (K24) will provide Dr. Ray with the opportunity to continue
her career development, mentorship of clinical investigators, and research in medications development for
alcoholism. Consistent with the goal of supporting Dr. Ray’s career trajectory in AUD treatment development,
the research aims are comprised of projects that will allow her to extend the impact of her research program in
the areas of (a) neuroscience, (b) clinical trials, and (c) advanced quantitative methods. The ultimate research
goal of the proposal is to integrate basic neuroscience and clinical trials methods to medications development
for AUD. The mentoring plan will focus on continued training of undergraduate students, graduate students in
clinical psychology, psychiatric residents, postdoctoral fellows, and junior faculty to conduct patient-oriented
alcohol research. Dr. Ray will provide training in areas of clinical research methods, data analysis, data
interpretation, manuscript preparation, grantsmanship, research ethics, and professional development.
Mentoring occurs through Dr. Ray’s active research laboratory, which includes weekly individual and group
meetings with trainees. Dr. Ray is active in providing lectures and seminars through multiple training programs
at UCLA. In particular, Dr. Ray is committed to mentoring students from underrepresented backgrounds and as
a Latina scientist, is sensitive to the issues of diversity in science. Through active participation in multiple
programs aimed at diversifying the pool of alcohol scientists, Dr. Ray will broaden her impact in this arena. The
training plan consists of coursework and training experiences in areas that are important to her career
development as an investigator and mentor, particularly in the topics of basic neuroscience, clinical trials, and
advanced quantitative methods. An outstanding group of collaborators has agreed to support Dr. Ray in her
training goals. These areas of training and professional development have been selected in synergy with the
research aims and ongoing funded-projects in Dr. Ray’s laboratory with the overarching goal of broadening the
impact of her research program as well as that of her mentees. In summary, the support of the Mid-Career
Investigator Award (K24) will allow Dr. Ray to devote her effort to patient-oriented alcohol research and
research mentoring. She will also develop her own skill set through proposed training in basic neuroscience of
AUD, clinical trials, and advanced quantitative methods while continuing to actively disseminate research
findings along with her mentees through scientific presentations and publications. Through her mentoring, Dr.
Ray is committed to training the new generation of patient-oriented alcohol researchers and will prioritize
efforts to diversify the pool of junior scientists in the field of alcohol research.
项目摘要/摘要
申请职业生涯中期研究人员奖(K24)将为雷博士提供继续
她的职业发展、临床研究人员的指导以及药物开发方面的研究
酗酒。与支持Ray博士在AUD治疗开发方面的职业轨迹的目标一致,
研究目标由项目组成,这些项目将使她能够扩大她的研究计划在
(A)神经科学,(B)临床试验,和(C)先进的定量方法。终极研究
该提案的目标是将基础神经科学和临床试验方法整合到药物开发中
换成澳元。导师计划将重点放在继续培训本科生、研究生和
临床心理学、精神科住院医师、博士后研究员和初级教员以病人为导向
酒精研究。Ray博士将在临床研究方法、数据分析、数据
口译、手稿准备、专业技能、研究道德和专业发展。
辅导通过Ray博士的主动研究实验室进行,该实验室包括每周个人和小组
与实习生会面。雷博士积极通过多个培训项目提供讲座和研讨会
在加州大学洛杉矶分校。尤其是,雷博士致力于指导来自代表性不足的背景的学生,以及
一位拉丁裔科学家,对科学中的多样性问题很敏感。通过积极参与多个
旨在使酒精科学家群体多样化的项目,雷博士将扩大她在这一领域的影响力。这个
培训计划包括对她的职业生涯很重要的领域的课程工作和培训经验
作为研究人员和导师的发展,特别是在基础神经科学、临床试验和
先进的量化方法。一群杰出的合作者已经同意支持雷博士
培训目标。这些培训和专业发展领域的选择是与
雷博士实验室的研究目标和正在进行的资助项目,首要目标是扩大
她的研究计划以及她的导师的影响。总而言之,对职业生涯中期的支持
研究员奖(K24)将允许雷博士致力于以患者为导向的酒精研究和
研究指导。她还将通过拟议的基础神经科学培训来发展自己的技能。
AUD、临床试验和先进的定量方法,同时继续积极传播研究
通过科学报告和出版物,她与她的导师们一起研究了这一发现。通过她的指导,Dr。
雷致力于培养新一代以患者为导向的酒精研究人员,并将优先考虑
努力使酒精研究领域的初级科学家队伍多样化。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ibudilast moderates the effect of mood on alcohol craving during stress exposure.
- DOI:10.1037/pha0000458
- 发表时间:2022-10
- 期刊:
- 影响因子:2.3
- 作者:Meredith LR;Green R;Grodin EN;Chorpita M;Miotto K;Ray LA
- 通讯作者:Ray LA
Alcohol Use Among Treatment-Seeking Individuals With Opioid Use Disorder.
寻求治疗的阿片类药物使用障碍患者的饮酒情况。
- DOI:10.15288/jsad.22-00176
- 发表时间:2023
- 期刊:
- 影响因子:3.4
- 作者:Baskerville,Wave-Ananda;Grodin,EricaN;Lin,Johnny;Miotto,Karen;Mooney,LarissaJ;Ray,LaraA
- 通讯作者:Ray,LaraA
Alcohol use trajectories among U.S. adults during the first 42 weeks of the COVID-19 pandemic.
- DOI:10.1111/acer.14824
- 发表时间:2022-06
- 期刊:
- 影响因子:0
- 作者:Leventhal, Adam M.;Cho, Junhan;Ray, Lara A.;Pacula, Rosalie Liccardo;Lee, Brian P.;Terrault, Norah;Pedersen, Eric;Lee, Jungeun Olivia;Davis, Jordan P.;Jin, Haomiao;Huh, Jimi;Wilson, John P.;Whaley, Reid C.
- 通讯作者:Whaley, Reid C.
Evaluation of delay discounting as a transdiagnostic research domain criteria indicator in 1388 general community adults.
- DOI:10.1017/s0033291721005110
- 发表时间:2023-03
- 期刊:
- 影响因子:6.9
- 作者:Levitt, E. E.;Oshri, A.;Amlung, M.;Ray, L. A.;Sanchez-Roige, S.;Palmer, A. A.;MacKillop, J.
- 通讯作者:MacKillop, J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARA A. RAY其他文献
LARA A. RAY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARA A. RAY', 18)}}的其他基金
The effects of stress on decision-making in alcohol use disorder: A translational approach
压力对酒精使用障碍决策的影响:转化方法
- 批准号:
10667891 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Translational underpinnings of motivation for alcohol in humans
人类饮酒动机的转化基础
- 批准号:
10345709 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Integrating findings across stages of medication development for AUD
整合 AUD 药物开发各个阶段的发现
- 批准号:
10353926 - 财政年份:2021
- 资助金额:
$ 18.39万 - 项目类别:
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
用于筛选酒精使用障碍药物的新型人体实验室模型
- 批准号:
10387543 - 财政年份:2021
- 资助金额:
$ 18.39万 - 项目类别:
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder
神经免疫调节剂异丁司特治疗酒精使用障碍的随机对照临床试验
- 批准号:
10387454 - 财政年份:2021
- 资助金额:
$ 18.39万 - 项目类别:
Integrating findings across stages of medication development for AUD
整合 AUD 药物开发各个阶段的发现
- 批准号:
10491120 - 财政年份:2021
- 资助金额:
$ 18.39万 - 项目类别:
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
用于筛选酒精使用障碍药物的新型人体实验室模型
- 批准号:
10019310 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
A NOVEL HUMAN LABORATORY MODEL FOR SCREENING MEDICATIONS FOR ALCOHOL USE DISORDER
用于筛选酒精使用障碍药物的新型人体实验室模型
- 批准号:
10095672 - 财政年份:2019
- 资助金额:
$ 18.39万 - 项目类别:
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder
神经免疫调节剂异丁司特治疗酒精使用障碍的随机对照临床试验
- 批准号:
9883692 - 财政年份:2018
- 资助金额:
$ 18.39万 - 项目类别:
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
酗酒的临床神经科学:神经科学与临床试验的结合
- 批准号:
10242146 - 财政年份:2018
- 资助金额:
$ 18.39万 - 项目类别:
相似海外基金
The investigation of chronic alcohol consumption enhanced aging colon in elder mice and the mechanism of suppressed on aging colon tissues by sesame lignans continuous intake
长期饮酒促进老年小鼠结肠衰老的研究及持续摄入芝麻木脂素抑制结肠组织衰老的机制
- 批准号:
23K10904 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
- 批准号:
23K05734 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Internal Sources of Minority Stress and Alcohol Consumption
少数群体压力和饮酒的内部根源
- 批准号:
10742318 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Characterizing the Relationship Between Alcohol Consumption and Neuron-Derived Exosomal MicroRNA Cargo in an Adolescent-Young Adult Twin Cohort
青少年双胞胎队列中酒精消耗与神经元衍生的外泌体 MicroRNA 货物之间关系的表征
- 批准号:
10452928 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别:
Endocrine regulation of alcohol consumption and fear learning
饮酒和恐惧学习的内分泌调节
- 批准号:
10483780 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别:
The impact of friends sharing different modalities of alcohol-related social media content on alcohol consumption: A longitudinal examination of changes in content shared by social networks over time
朋友分享不同形式的酒精相关社交媒体内容对饮酒的影响:对社交网络分享内容随时间变化的纵向研究
- 批准号:
10534428 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
- 批准号:
10339931 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别:
Chronic alcohol consumption results in elevated Autotaxin levels that suppress anti-tumor immunity
长期饮酒会导致自分泌运动因子水平升高,从而抑制抗肿瘤免疫力
- 批准号:
10370159 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
- 批准号:
10595096 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别:
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
基于技术的评估和干预,以减少佛罗里达队列的饮酒量并改善艾滋病病毒抑制
- 批准号:
10707386 - 财政年份:2022
- 资助金额:
$ 18.39万 - 项目类别: